V. Piccialli et al. / Tetrahedron 64 (2008) 11185–11192
11191
CHCl3 (7.26 ppm) or pyridine signals (8.71, 7.56, 7.19 ppm); 13C NMR
4.2.3. Compound 4
chemical shifts were referenced to the solvent (CDCl3, 77.0 ppm;
pyridine-d5, 149.9, 135.5, 123.5 ppm). Abbreviations for signal
coupling are as follows: s, singlet; d, doublet; t, triplet; q, quartet;
m, multiplet, br, broad. J values are given in hertz. One-dimensional
1H and 13C NMR spectra were acquired under standard conditions.
The pulse programs of the gCOSY, gHSQC, TOCSY, gHMBC, NOESY
and HSQC-TOCSYexperiments were taken from the Varian software
library. The gHSQC experiments were optimized for a one-bond
heteronuclear coupling constant of 145 Hz. The gHMBC experi-
ments were optimized for long-range coupling constants of 8 Hz.
Two-dimensional TOCSY experiments were acquired with a mixing
time of 80 ms while NOESY spectra were acquired with mixing
times of 80, 200 and 350 ms.
IR spectra were collected on a Jasco FTIR-430 spectrometer. ESI
mass spectrometric analyses were recorded on a Waters Micromass
ZQ mass spectrometer equipped with an Electrospray source used
in the positive mode. HRESIMS spectra were recorded on a Bruker
APEX II FT-ICR mass spectrometer using electron spray ionization
(ESI) technique in positive mode. HREIMS spectra were recorded on
a Fisons VG Prospect mass spectrometer.
Oil. 1H NMR (300 MHz, CDCl3):
d
5.76 (2H, dd, J¼17.6, 11.0, H-17
and H-19), 5.10 (2H, dd, J¼11.0, 1.6, Ha-18 and Ha-20), 5.08 (2H, br t,
overlapped with the Ha-18/Ha-20 protons, J¼7.5, H-3 and H-10),
4.88 (2H, dd, J¼17.6, 1.6, Hb-18 and Hb-20), 1.67, 1.56 (6H each, s,
vinyl methyls), 0.93 (6H, s, CH3-14 and CH3-15). 13C NMR (75 MHz,
CDCl3):
d 16.3, 17.6, 23.37, 25.7, 34.7, 45.3, 113.8, 125.4, 130.9, 144.1.
HREIMS calcd for C20H34 274.2661, found 274.2675 (Mþ).
4.3. Oxidative cyclization of 2
To a solution of digeranyl (2, 156 mg, 0.569 mmol) in the bi-
phasic mixture EtOAc/CH3CN/H2O (3:3:1) (50 mL) were added in
sequence NaIO4 (6 equiv, 732 mg, 3.41 mmol) and RuO2$2H2O
(20 mol %, 15.2 mg, 0.11 mmol) under vigorous stirring at 0 ꢁC. After
20 min a saturated Na2S2O3$5H2O solution (1 mL) was added and,
after a further 10 min stirring, the mixture was extracted with
EtOAc (3ꢀ10 mL). The combined organic phase was dried and
evaporated to give 152 mg of an oily product. HPLC separation
(250ꢀ10 mm column, hexane–EtOAc, 55:45, flow 2.5 mL/min,
30 mg/injection) afforded tris-THF diol
6
(10.1 mg, 5%,
tR¼19.5 min), tris-THF diol 5 (18.2 mg, 9%, tR¼22.0 min) and bis-
4.2. Synthesis of tetraene 2
THF lactone 7 (26.6 mg, 15%, tR¼32.5 min) as oils.
To geraniol (2.15 g, 13.95 mmol) dissolved in anhydrous THF
4.3.1. Compound 5
(10 mL), phosphorous tribromide (0.4 equiv, 5.6 mmol, 530
mL) was
Oil. IR (neat) nmax 3420 (br) cmꢂ1
.
1H NMR (500 MHz, CDCl3,
added dropwise under stirring, at room temperature. When the
starting product disappeared (30 min, TLC monitoring, hexane–
EtOAc, 7:3), ice was added and stirring continued for further
a 10 min. The mixture was extracted with hexane (3ꢀ10 mL), dried
and taken to dryness in vacuo to give geranyl bromide (2.472 g,
82%) that was used in the next step without further purification.
Crude geranyl bromide (1.884 g, 8.65 mmol) was dissolved in an-
hydrous and strictly deoxygenated THF (20 mL), then Cp2TiCl
(431 mg, 0.2 equiv, 1.73 mmol) was added followed by portionwise
addition of Mn dust (3.80 g, 8 equiv, 69.2 mmol), under an argon
atmosphere. The red-wine solution turned to green within 2–
3 min. After 5 min, TLC analysis (hexane/EtOAc, 95:5) revealed the
disappearance of the starting allyl halide (Rf¼0.6) and formation of
a product at Rf¼0.8. The mixture was diluted with ether and 1 N HCl
was cautiously added (gas evolution) until effervescence ceased.
The mixture was extracted with t-BuOMe (3ꢀ10 mL), dried and
concentrated under reduced pressure to give an oily product
(1.215 g) that was filtered on a short pad of silica gel eluting with
hexane/t-BuOMe (4:1). 1H NMR analysis showed the crude reaction
attributions by 2D NMR): d 3.95–3.90 (1H, m, H-10), 3.90–3.86 (1H,
dd, J¼8.2, 4.0, H-3), 3.84–3.79 (1H, m, H-7), 3.73 (1H, dd, J¼9.2, 5.9,
H-14), 2.28 (1H, m, Ha-5), 1.60 (Hb-5), 2.18, 1.65 (H2-12), 2.10, 1.98
(H2-4), 1.97 (H2-9), 1.96 (H2-8), 1.85, 1.75 (H2-13), 1.24 (3H, s, Me-1),
1.18 (3H, s, Me-20), 1.12 (3H, s, Me-18), 1.11 (3H, s, Me-16), 1.10 (3H,
s, Me-19), 1.08 (3H, s, Me-17). 1H NMR (500 MHz, pyridine-d5, at-
tributions by 2D NMR):
d
4.04 (1H, dd, J¼8.4, 6.8, H-14), 4.02–3.98
(1H, m, H-10), 3.95 (1H, dd, J¼7.2, 6.2, H-3), 3.94–3.90 (1H, m, H-7),
2.25, 1.52 (H2-5), 2.23, 1.61 (H2-12), 2.10, 1.90 (H2-4), 2.00, 1.98 (H2-
13), 1.93, 1.86 (H2-9), 1.90, 1.88 (H2-8), 1.39 (3H, s, Me-1), 1.37 (3H, s,
Me-16), 1.33 (3H, s, Me-20), 1.25 (3H, s, Me-17), 1.13 (6H, s, Me-18,
Me-19). 13C NMR (125 MHz, CDCl3):
d 87.1 (CH-14), 86.1 (CH-3), 85.1
(CH-10), 84.9 (CH-7), 84.0 (C-11), 83.3 (C-6), 72.2 (C-2), 70.7 (C-15),
35.1 (CH2-5), 35.0 (CH2-12), 27.9 (CH3-1), 27.4 (CH3-20), 27.1 (CH2-
9), 26.8 (CH2-13), 25.8 (CH2-4), 25.2 (CH3-17), 24.6 (CH3-18), 23.9
(CH3-19), 23.7 (CH3-16). HRESIMS calcd for C20H36NaO5 379.2460,
found 379.2481 (MþNa)þ.
4.3.2. Compound 6
product to be composed by a mixture of
a
,a
0- and
a,
g0 coupling
Oil. IR (neat) nmax 3420 cmꢂ1
.
1H NMR (500 MHz, CDCl3, attri-
products in a 3.5:1 approximate ratio. The crude mixture (906 mg)
was further chromatographed on AgNO3 (20%)-impregnated silica
gel. Slow elution with hexane/EtOAc (98:2) gave pure 2 (581 mg,
butions by 2D NMR): d 3.93 (2H, m, H-7 and H-10), 3.84 (2H, dd,
J¼7.3, 5.8, H-3 and H-14), 2.20–2.13 (1H, m, Ha-5 and Ha-12), 1.62
(Hb-5 and Hb-12), 2.04, 1.92 (H2-4 and H2-13), 2.00, 1.91 (H2-8 and
H2-9), 1.24 (6H, s, Me-1 and Me-16), 1.13 (6H, s, Me-18 and Me-19),
1.07 (6H, s, Me-17 and Me-20). 1H NMR (500 MHz, pyridine-d5,
70%), the
amount of the
a,
g0 coupling isomer 3 (166 mg, 20%) as well as a minute
g,
g0 coupling isomer 4 (16.5 mg, 2%).
attributions by 2D NMR):
d
3.97 (2H, br t, J¼5.9, H-7 and H-10), 3.88
4.2.1. Compound 23,4
(2H, t, J¼7.0, H-3 and H-14), 2.19, 1.50 (H2-5 and H2-12), 2.06, 1.84
(H2-4 and H2-13), 1.83 (H2-8 and H2-9), 1.40 (6H, s, Me-1 and Me-
16), 1.12 (6H, s, Me-18 and Me-19), 1.21 (6H, s, Me-17 and Me-20).
Oil. 1H NMR (300 MHz, CDCl3):
d 5.19–5.05 (4H, m, olefinic
protons), 2.13–1.92 (12H, m), 1.68 (6H, s), 1.60 (12H, s). 13C NMR
(75 MHz, CDCl3):
d
15.9, 17.6, 25.6, 26.7, 28.1, 39.7, 124.2, 124.3, 131.1,
13C NMR (125 MHz, CDCl3):
d 86.1 (CH-3, CH-14), 85.5 (CH-7, CH-
134.9. HREIMS calcd for C20H34 274.2661, found 274.2650 (Mþ).
10), 83.8 (C-6, C-11), 71.8 (C-2, C-15), 35.4 (CH2-5, CH2-12), 28.3
(CH2-8, CH2-9), 28.1 (CH3-1, CH3-16), 26.3 (CH2-4, CH2-13), 25.3
(CH3-17, CH3-20), 23.6 (CH3-18, CH3-19). HRESIMS calcd for
C20H36NaO5 379.2460, found 379.2475 (MþNa)þ.
4.2.2. Compound 35
Oil. 1H NMR (300 MHz, CDCl3):
d
5.74 (1H, dd, J¼17.7, 11.0, H-19),
5.08 (3H two apparent br t, overlapping, both J¼6.0, H-3, H-7, H-
12), 4.98 (1H, dd, J¼11.0, 1.7, Ha-20), 4.90 (1H, dd, J¼17.7, 1.7, Hb-20),
2.12–1.92 (8H, m), 1.67 (6H, br s, 2ꢀvinyl methyls), 1.60 (6H, br s,
2ꢀvinyl methyls), 1.58 (3H, s, vinyl methyl), 1.35–1.25 (2H, m), 0.95
(3H, s, CH3-17). HREIMS calcd for C20H34 274.2661, found 274.2681
(Mþ).
4.3.3. Compound 7
Oil. IR (neat) nmax 3422 (br), 1766 cmꢂ1 1H NMR (500 MHz,
.
CDCl3, attributions by 2D NMR):
d
3.96 (1H, t, J¼7.7, H-10), 3.87 (1H,
dd, J¼8.0, 4.9, H-3), 3.84 (1H, dd, J¼9.7, 5.2, H-7), 2.82–2.68 (1H, m,
H2-13), 2.50 (1H, dd, J¼10.8, 3.3, H2-13), 2.44, 1.96 (2H, H2-12), 2.15,